Clinical Trial Update: Electron Beam Radiotherapy for the Treatment of Refractory Sclerodermatous Chronic Graft Versus Host Disease [EARLY_Phase 1]

View source ↗

Summary

The EARLY Phase 1 trial of Electron Beam Radiotherapy for refractory sclerodermatous chronic graft-versus-host disease (NCT05515692) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: City of Hope Medical Center | Conditions: Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm | EARLY_Phase 1 | Status: WITHDRAWN